Eyevance

Marketing image for one of Eyevance Pharmaceuticals' products, Flarex. [eyevance.com]

Fort Worth Ophthalmic Biotech Eyevance Exits to Japanese Firm for $225M

by | Sep 17, 2020
Eyevance Pharmaceuticals, which develops and commercializes ophthalmic products, has been purchased for $225 million by Santen, a Japanese leader in ophthalmology. Eyevance will join Santen's U.S. organization.
MORE►
Alcon
The (Alcon) Family Tree: How One Company Seeded a DFW Life Science Legacy
by | Jan 21, 2020
Alcon gave rise to a startup ecosystem in North Texas that is spreading into all parts of how drugs, medical devices, and more are created.
MORE►
funding
Follow the Money: Impact Shares Gets $1M from Rockefeller Foundation, Phynd Adds $4M in VC round
by | Oct 25, 2018
You'll also find news from WiredScore, Jacobs Engineering, BNSF Railway and GE Transportation, as well as Bay Capital Ventures and Eyevance. Here are notable funding and acquisition deals with North Texas ties.
MORE►
A Special Thank you to our sponsors

A collaboration of the Dallas Regional Chamber and Dallas Next, Dallas Innovates is an online news platform covering what's new + next in Dallas - Fort Worth innovation.

© Copyright 2024 | All rights reserved.

Business

Creative

Education

Impact

Invention

Startup

Our Sponsors

Our Partners